Anaplastic lymphoma kinase gene rearrangement occurs in 2–7% of non-small cell lung cancer (NSCLC) patients, especially in young, female, adenocarcinoma, non-smoking patients [2]. Here, ALK is linked to non-small cell lung carcinoma.